Skip to Main Content

Paper Details

The European NAFLD Registry: A real-world longitudinal cohort study of nonalcoholic fatty liver disease.
Contemp Clin Trials
64
2020
NAFLD, NASH, Non-Alcoholic Fatty Liver Disease, Steatohepatitis, cirrhosis, dyslipidaemia, fat accumulation, hepatocellular carcinoma, hypertension, liver disease, liver fibrosis, necroinflammatory, non-alcoholic steatohepatitis, nonalcoholic fatty liver disease, obesity, patient, type 2 diabetes
Author NameAffiliation
Mary Julia BrosnanPfizer Inc.
Stephen A HarrisonUniversity of Oxford
  • 1 - 2

Datasets

Release 1.2